The stain wars.
Olsson
Gunnar O
GO
Blasetto
James W
JW
Bryzinski
Brian S
BS
Caplan
Richard J
RJ
Gold
Alex
A
D002986:Clinical Trials as Topic / Q000592:standards; D003132:Commerce / Q000592:standards; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval / Q000706:statistics & numerical data; D004345:Drug Industry / Q000941:ethics / Q000592:standards*; D005464:Fluorobenzenes / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy; D010330:Patents as Topic / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium